A FDA advisory panel concluded that a Biogen treatment for a rare, genetic form ...
Sens. Elizabeth Warren, Jeff Merkley are blasting Medicare Advantage insurers fo...
Physician Jim O'Connell says his nonprofit is "not solving homelessness, but car...
Former surgeon general Jerome Adams has emerged as a leading voice on public hea...
Health plan sponsors are excluding pricey specialty drugs from coverage, then ta...
Seagen generated almost $2bn in revenue in 2022, an increase approaching 25% fro...
In 2022, the biotech IPO market saw fewer offerings, and those that did manage t...
Biohaven is expecting to advance Hangzhou Highlightll’s BHV-8000 into a Phase I ...
While lifestyle modifications play a key role in treating PCOS, the paucity of n...
Incyte’s Zynyz is approved based on the data obtained from the POD1UM-201 trial.
Mass spectrometry is one of the most versatile technologies you can integrate in...
The MHRA introduces new changes to UK clinical trial regulation in hopes of reco...
A clear issue currently facing gastroenterologists treating CD is the lack of in...
CSPC Pharmaceutical’s SYS6006 has been designed to target some major Omicron var...
Healthcare providers are under pressure to address the growing issue of substanc...
In nearly a month, the number of confirmed and probable cases has grown from nin...
